These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1505119)

  • 1. The beta-2-glycoprotein I and antiphospholipid antibodies.
    Shoenfeld Y; Meroni PL
    Clin Exp Rheumatol; 1992; 10(2):205-9. PubMed ID: 1505119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
    Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
    Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now?
    Inanç M; Radway-Bright EL; Isenberg DA
    Br J Rheumatol; 1997 Dec; 36(12):1247-57. PubMed ID: 9448584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New facet of antiphospholipid antibodies.
    Valesini G; Alessandri C
    Ann N Y Acad Sci; 2005 Jun; 1051():487-97. PubMed ID: 16126989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens.
    Buschmann C; Fischer C; Ochsenhirt V; Neukirch C; Lackner KJ; von Landenberg P
    Ann N Y Acad Sci; 2005 Jun; 1051():240-54. PubMed ID: 16126965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection.
    Hunt JE; McNeil HP; Morgan GJ; Crameri RM; Krilis SA
    Lupus; 1992 Feb; 1(2):75-81. PubMed ID: 1301967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
    Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
    Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
    Bertolaccini ML; Hughes GR; Khamashta MA
    Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoantibodies and thrombosis].
    Koike T
    Hokkaido Igaku Zasshi; 1997 Sep; 72(5):485-90. PubMed ID: 9363465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I.
    Oosting JD; Derksen RH; Entjes HT; Bouma BN; de Groot PG
    Thromb Haemost; 1992 May; 67(5):499-502. PubMed ID: 1519207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid.
    Gharavi AE; Sammaritano LR; Wen J; Miyawaki N; Morse JH; Zarrabi MH; Lockshin MD
    J Rheumatol; 1994 Jan; 21(1):94-9. PubMed ID: 8151598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid cofactor.
    Gharavi AE
    Stroke; 1992 Feb; 23(2 Suppl):I7-10. PubMed ID: 1561674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of anti-beta 2-glycoprotein I antibodies.
    Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():15-7. PubMed ID: 8952753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor.
    Valesini G; Shoenfeld Y
    Autoimmunity; 1992; 14(2):105-10. PubMed ID: 1303677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
    Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
    J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do patients with antiphospholipid syndrome have autoantibodies to beta 2-glycoprotein I?
    Gharavi AE; Harris EN; Sammaritano LR; Pierangeli SS; Wen J
    J Lab Clin Med; 1993 Oct; 122(4):426-31. PubMed ID: 8228557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoreactive CD4(+) T cells to beta(2)-glycoprotein I in patients with antiphospholipid syndrome.
    Kuwana M
    Autoimmun Rev; 2003 Jun; 2(4):192-8. PubMed ID: 12848945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.